<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Press Coverage

Long-term dupilumab treatment of OCS-dependent asthma reduced OCS use

Default sub title

Author Healio | Publish Date June 22, 2021

Long-term treatment with dupilumab helped patients with oral corticosteroid-dependent asthma wean their oral corticosteroid use and also reduced exacerbations and improved lung function.